Detalles de la búsqueda
1.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104758
2.
Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule.
Cancer Cell Int
; 9: 27, 2009 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-19874583
3.
MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
Mol Endocrinol
; 21(11): 2725-37, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17717071
4.
Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line.
Endocrinology
; 145(9): 4192-203, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15142990
5.
Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha.
J Cell Biochem
; 86(4): 759-72, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12210742
6.
Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening.
Mol Hum Reprod
; 8(9): 871-9, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12200466
Resultados
1 -
6
de 6
1
Próxima >
>>